Table 3 Results of a 52-week Monotherapy Trial in Adults with Type 2 Diabetes Mellitus a Figure 3 Mean HbA 1c for Adult Patients with Type 2 Diabetes Mellitus who Completed the 52-week Trial and for the Last Observation Carried Forward (LOCF, intent-to-treat) data at Week 52 (Monotherapy) Combination Therapy Add-on to Metformin In this 26-week trial, 1,091 adult patients with type 2 diabetes mellitus were randomized to liraglutide injection 0.6 mg, liraglutide injection 1.2 mg, liraglutide injection 1.8 mg, placebo, or glimepiride 4 mg (one-half of the maximal approved dose in the United States), all as add-on to metformin
Tirzepatide suppresses appetite so effectively that many users dramatically undereat without realizing it
GLP-1 medications such as semaglutide work through a different pathway than thyroid hormonesthey slow stomach emptying and regulate hunger signals in the brain
One factor could be the medical community's prescribing habits
Easy to DigestFormulated for rapid absorption and minimal digestive discomfort, suitable for frequent use
A doctor can adjust your dose of semaglutide, prescribe other medication to help, or rule out other medical diagnoses that might be making the belching worse
